Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by INNES, J.
Right arrow Articles by RIDER, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by INNES, J.
Right arrow Articles by RIDER, W. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1955, Vol. 10, No. 3, pp. 252-258.
© 1955 American Society of Hematology, Inc.


Multiple Myelomatosis Treated with a Combination of Urethane and an Oral Nitrogen Mustard

JAMES INNES 1 and W. D. RIDER 1

1 Departments of Medicine and Radiotherapy, University of Edinburgh.

1. 17 Cases of advanced multiple myelomatosis have been treated with combined chemotherapy using small doses of urethane and an oral preparation of nitrogen mustard.

2. The object of such therapy was to test the hypothesis that a synergistic action existed between these compounds.

3. The results indicate that significant palliation was obtained in many patients treated and that in some the progress of the disease was modified.

4. In the dosage employed such combined therapy appears to be free from undesirable toxic manifestations and suitable for out-patient administration over long periods.

Submitted on May 20, 1954
Accepted on July 30, 1954


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1955 by American Society of Hematology         Online ISSN: 1528-0020